News

HER3-targeted antibody-drug conjugate shows promise for treatment-resistant solid tumors
A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...
Olfactory neurons use unexpected 'solid' clusters to achieve genetic precision
A new study published in Nature reveals how olfactory sensory neurons (OSNs) achieve extraordinary precision in selecting ...
Natural Killer (NK)-Cell Lymphoma Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...
Phys.org on MSN4h
Researchers reveal structural basis of prostaglandin D2 receptor DP1 activation and its implications for drug design
Recent breakthroughs in understanding the prostaglandin D2 (PGD2) receptor 1 (DP1) are paving the way for innovative ...
News-Medical.Net on MSN13h
TTF1 identified as key biomarker for advanced KRAS G12C-mutated non-small cell lung cancer
Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...
Food as friend, not foe—study maps cellular network that enables safe food consumption through oral tolerance
If we have an allergy to peanuts, strawberries or dairy, we are quick to blame our immune systems. But when we enjoy a ...
Frontiers15h
Molecular and cellular mechanisms underpinning adaptation and recovery after spinal cord injury
Spinal cord injury (SCI) is a devastating, debilitating, and life-altering condition that currently lacks a definitive cure or highly effective treatment ...
Frontiers10h
Advanced Vaccine Formulations for Overcoming Skin and Mucosal Barriers
Skin and mucosal delivery is a rapidly evolving field aiming to provide safer and patient-friendly alternatives to conventional treatment options, but also ...